Stay updated on Midostaurin Combo with Chemo in FLT3 AML Clinical Trial
Sign up to get notified when there's something new on the Midostaurin Combo with Chemo in FLT3 AML Clinical Trial page.

Latest updates to the Midostaurin Combo with Chemo in FLT3 AML Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedA note now states that publications are automatically filled from PubMed and may not all pertain to the study; the revision has been updated to v3.3.2 (from v3.2.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check19 days agoChange DetectedDeletion of the government funding/status notice from the page; the study details and content remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check41 days agoChange DetectedNo significant changes detected between the two screenshots. Page content and layout appear unchanged, including the Study Overview, Eligibility Criteria, and Contacts sections.SummaryDifference0.2%

- Check63 days agoChange Detected- Added a government funding lapse notice with operating status guidance and links; included current operating status reminders. - Updated version to v3.2.0 and removed the old v3.0.2 reference.SummaryDifference2%

- Check84 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; no other content changes detected.SummaryDifference0.0%

- Check91 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1.SummaryDifference0.0%

Stay in the know with updates to Midostaurin Combo with Chemo in FLT3 AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Midostaurin Combo with Chemo in FLT3 AML Clinical Trial page.